Navellier & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-3,477
| Closed | -$406K | – | 322 |
|
|
2016
Q2 | $406K | Buy |
3,477
+17
| +0.5% | +$1.99K | 0.06% | 154 |
|
|
2016
Q1 | $482K | Sell |
3,460
-70
| -2% | -$9.75K | 0.06% | 127 |
|
|
2015
Q4 | $673K | Sell |
3,530
-136
| -4% | -$25.9K | 0.07% | 104 |
|
|
2015
Q3 | $573K | Hold |
3,666
| – | – | 0.06% | 136 |
|
|
2015
Q2 | $663K | Hold |
3,666
| – | – | 0.06% | 161 |
|
|
2015
Q1 | $635K | Hold |
3,666
| – | – | 0.06% | 159 |
|
|
2014
Q4 | $678K | Sell |
3,666
-77
| -2% | -$14.2K | 0.03% | 150 |
|
|
2014
Q3 | $621K | Hold |
3,743
| – | – | 0.03% | 151 |
|
|
2014
Q2 | $585K | Sell |
3,743
-517
| -12% | -$80.8K | 0.03% | 164 |
|
|
2014
Q1 | $648K | Sell |
4,260
-257
| -6% | -$39.1K | 0.03% | 134 |
|
|
2013
Q4 | $600K | Sell |
4,517
-4,885
| -52% | -$649K | 0.03% | 151 |
|
|
2013
Q3 | $1.09M | Sell |
9,402
-4,098
| -30% | -$476K | 0.03% | 119 |
|
|
2013
Q2 | $1.25M | Buy |
+13,500
| New | +$1.25M | 0.06% | 92 |
|